Evidence map›Paper›PMID 29137232›Full record

ArticleOncotarget2017

Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.

Louise Y Fong, Ruiyan Jing, Karl J Smalley, Cristian Taccioli, Johannes Fahrmann, Dinesh K Barupal, Hansjuerg Alder, John L Farber, Oliver Fiehn, Carlo M Croce

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Louise Y FongDepartment of Pathology, Anatomy & Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Ruiyan JingDepartment of Pathology, Anatomy & Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Karl J SmalleySidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Cristian TaccioliAnimal Medicine, Production and Health Department, University of Padua, Padua, Italy.
Johannes FahrmannUniversity of California, Davis, West Coast Metabolomics Center, Davis, CA, USA.
Dinesh K BarupalUniversity of California, Davis, West Coast Metabolomics Center, Davis, CA, USA.
Hansjuerg AlderDepartment of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
John L FarberDepartment of Pathology, Anatomy & Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Oliver FiehnUniversity of California, Davis, West Coast Metabolomics Center, Davis, CA, USA.
Carlo M CroceDepartment of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Thomas Jefferson University · USUniversity of California, Davis · USThe Ohio State University · USSidney Kimmel Cancer Center · USUniversity of Padua · IT

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
Chemoprevention of upper aerodigestive tract cancer by dietary zincR01CA118560 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FONG, LOUISE Y.Y. · 2006 to 2017
$2.7M
Molecular Mechanisms of Cachexia in Lung CancerR01CA190740 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M, NANASINKAM, SERGE PATRICK · 2015 to 2019
$2.1M
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA118560NCI NIH HHS R01 CA190740NCI NIH HHS R35 CA197706NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) in humans is a deadly disease associated with dietary zinc (Zn)-deficiency. In the rat esophagus, Zn-deficiency induces cell proliferation, alters mRNA and microRNA gene expression, and promotes ESCC. We investigated whether Zn-deficiency alters cell metabolism by evaluating metabolomic profiles of esophageal epithelia from Zn-deficient and replenished rats

Indexed as

dietary zinc-deficiencyesophageal neoplasiametabolomic profilingmiR-143 - Hk2 - glucose signalingtranscriptomics and microRNA profiling integration

Identifiers

PMID29137232
PMCPMC5669858
OpenAlexW2623178908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.